[1]
D. Maltsev, «Effectiveness of long-term continuous immunomodulatory therapy with gamma-recombinant interferon in patients with clinically manifest forms of neutrophil myeloperoxidase deficiency», AVFT, vol. 39, n.º 5, feb. 2021.